These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8236150)

  • 21. Biology of factor IX.
    Kurachi K; Kurachi S; Furukawa M; Yao SN
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):953-73. PubMed ID: 8148489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
    Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
    Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Arg-4 mutant factor IX Strasbourg 2 shows a delayed activation by factor XIa.
    de la Salle C; Charmantier JL; Ravanat C; Ohlmann P; Hartmann ML; Schuhler S; Bischoff R; Ebel C; Roecklin D; Balland A
    Nouv Rev Fr Hematol (1978); 1993; 35(5):473-80. PubMed ID: 8295821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic basis and carrier detection of hemophilia B of Chinese origin.
    Lin SW; Shen MC
    Thromb Haemost; 1993 Mar; 69(3):247-52. PubMed ID: 8470048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergy between transcription factors DBP and C/EBP compensates for a haemophilia B Leyden factor IX mutation.
    Picketts DJ; Lillicrap DP; Mueller CR
    Nat Genet; 1993 Feb; 3(2):175-9. PubMed ID: 8499951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of mutations in four hemophilia B patients of Turkish origin, including a novel deletion of base 6411.
    Cağlayan SH; Vielhaber E; Gürsel T; Aktuğlu G; Sommer SS
    Hum Mutat; 1994; 4(2):163-5. PubMed ID: 7981722
    [No Abstract]   [Full Text] [Related]  

  • 28. Microdeletions in the factor IX gene: three recurrences associated with a quasipalindromic sequence.
    Ketterling RP; Sommer SS
    Hum Mol Genet; 1994 Jan; 3(1):191-2. PubMed ID: 8162024
    [No Abstract]   [Full Text] [Related]  

  • 29. Antenatal diagnosis of haemophilia B by amplification and electrophoresis of an exon fragment with a short deletion.
    Ljung R; Green P; Sjörin E; Giannelli F; Nilsson IM
    Eur J Haematol; 1992 Oct; 49(4):215-8. PubMed ID: 1464363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural analysis of factor IX protein variants to predict functional aberration causing haemophilia B.
    Mukherjee S; Saha A; Biswas P; Mandal C; Ray K
    Haemophilia; 2008 Sep; 14(5):1076-81. PubMed ID: 18540896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of hemophilia B carriers using two novel dinucleotide polymorphisms and Hha I RFLP of the factor IX gene in Japanese subjects.
    Toyozumi H; Kojima T; Matsushita T; Hamaguchi M; Tanimoto M; Saito H
    Thromb Haemost; 1995 Oct; 74(4):1009-14. PubMed ID: 8560402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular biology of hemophilia B.
    Roberts HR
    Thromb Haemost; 1993 Jul; 70(1):1-9. PubMed ID: 8236083
    [No Abstract]   [Full Text] [Related]  

  • 33. Mutation analysis of haemophilia B in the Irish population: increased prevalence caused by founder effect.
    Jenkins PV; Egan H; Keenan C; O'Shea E; Smith OP; Nolan B; White B; O'Donnell J
    Haemophilia; 2008 Jul; 14(4):717-22. PubMed ID: 18479429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel missense mutation in the coagulation factor IX catalytic domain associated with severe haemophilia B--Factor IXDelhi.
    Mahajan A; Sharma A; Chavali S; Kabra M; Chowdhury MR; Srinivasan N; Bharadwaj D
    Haemophilia; 2004 Sep; 10(5):550-2. PubMed ID: 15357782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of a new mismatch PCR-RFLP technique for detection of G10430A common mutation present in moderate to mild haemophilia B patients belonging to Gujarati community from the western part of India.
    Quadros L; Ghosh K; Shetty S
    Haemophilia; 2008 May; 14(3):628-9. PubMed ID: 18393981
    [No Abstract]   [Full Text] [Related]  

  • 36. Towards gene therapy for haemophilia B using primary human keratinocytes.
    Gerrard AJ; Hudson DL; Brownlee GG; Watt FM
    Nat Genet; 1993 Feb; 3(2):180-3. PubMed ID: 8499952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemophilia B+ with inhibitor.
    Ludwig M; Schwaab R; Olek K; Brackmann HH; Egli H
    Thromb Haemost; 1988 Apr; 59(2):340. PubMed ID: 3388303
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluorescent PCR-based gene dose analysis for detection of deletion mutations in carriers of haemophilia.
    Devi GS; Arora N; Rajkumar SV; Edison ES; Srivastava A; Jayandharan GR
    Haemophilia; 2013 Nov; 19(6):e377-80. PubMed ID: 23855319
    [No Abstract]   [Full Text] [Related]  

  • 39. Haemophilia B Liverpool: a new British family with mild haemophilia B associated with a -6 G to A mutation in the factor IX promoter.
    Stowell KM; Figueiredo MS; Brownlee GG; Jones P; Bolton-Maggs PH
    Br J Haematol; 1993 Sep; 85(1):188-90. PubMed ID: 8251390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analyses in hemophilia B families: identification of six new mutations in the factor IX gene.
    Espinós C; Casaña P; Haya S; Cid AR; Aznar JA
    Haematologica; 2003 Feb; 88(2):235-6. PubMed ID: 12604421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.